Literature DB >> 26780100

Limitations in Translating Animal Studies to Humans in Cardiovascular Disease.

Sean Lal1, Amy Li2, Cristobal Dos Remedios2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26780100     DOI： 10.1007/s12265-016-9676-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  9 in total

1.  Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.

Authors:  Thomas G von Lueder; Bing H Wang; Andrew R Kompa; Li Huang; Randy Webb; Pierre Jordaan; Dan Atar; Henry Krum
Journal:  Circ Heart Fail       Date:  2014-10-31       Impact factor: 8.790

2.  Do Mice Need an Order of Fries to Be Relevant for Transplant Studies?

Authors:  D Sawinski; J S Maltzman
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

3.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences.

Authors:  E M McNally; R Kraft; M Bravo-Zehnder; D A Taylor; L A Leinwand
Journal:  J Mol Biol       Date:  1989-12-05       Impact factor: 5.469

4.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

5.  Trends in animal use at US research facilities.

Authors:  Justin Goodman; Alka Chandna; Katherine Roe
Journal:  J Med Ethics       Date:  2015-02-25       Impact factor: 2.903

Review 6.  Lost in translation: animal models and clinical trials in cancer treatment.

Authors:  Isabella Wy Mak; Nathan Evaniew; Michelle Ghert
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

7.  Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure.

Authors:  J M Pfeffer; M A Pfeffer
Journal:  Am J Med       Date:  1988-03-11       Impact factor: 4.965

8.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

Review 9.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310
  9 in total
  6 in total

Review 1.  Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective.

Authors:  C G Dos Remedios; A Li; S Lal
Journal:  Biophys Rev       Date:  2018-07-18

2.  3Rs and biophysics.

Authors:  Cris Dos Remedios; Michelle Peckham
Journal:  Biophys Rev       Date:  2017-08-24

3.  The Sydney Heart Bank: a core facility that goes the extra mile to advance cardiac research.

Authors:  Sabine van Dijk
Journal:  Biophys Rev       Date:  2020-06-10

Review 4.  The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.

Authors:  W Linke; C G Dos Remedios; S P Lal; A Li; J McNamara; A Keogh; P S Macdonald; R Cooke; E Ehler; R Knöll; S B Marston; J Stelzer; H Granzier; C Bezzina; S van Dijk; F De Man; G J M Stienen; J Odeberg; F Pontén; J van der Velden
Journal:  Biophys Rev       Date:  2017-08-14

5.  Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion.

Authors:  Srijon K Banerjee; Samantha D Huckuntod; Shalynn D Mills; Richard C Kurten; Roger D Pechous
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 6.  Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development.

Authors:  Xiying Lin; Jiayu Tang; Yan-Ru Lou
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.